Skip to search formSkip to main contentSkip to account menu

girisopam

Known as: 1-(3-chlorophenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Benzodiazepines

Narrower (2)

EGIS 5810GYKI 51189

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Binding of girisopam (a 2,3-benzodiazepine derivative) to the substantia nigra is prevented by lesioning of the striatonigral pathway
1997
1997
Selective interaction of homophtalazine derivatives with morphine.
1997
1997
Study of the bone marrow penetration of radioactivity after oral administration of radiolabelled girisopam (EGIS-5810) in mice.
Girisopam (EGIS-5810) is a potent anxiolytic compound. Recent in vitro studies with the substance, in Chinese hamster ovary cells… 
1997
1997
Changes in specific binding sites of girisopam after chemical and surgical lesions in the striato-nigral system.
1992
1992
Pharmacokinetic and metabolism studies on girisopam by chromatographic and spectrometric methods in humans.
1987
1987
Neuropharmacology of a new psychotropic 2,3-benzodiazepine.
1-(3-Chlorophenyl)-4-methyl-7,8-dimethoxy-5H-2,3-benzodiazepine (GYKI 51189) is a new analogue of tofisopam. Due to the novel… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)